UMIN ID: C000000399
Registered date:17/04/2006
Cohort study to investigate the clinical factors associated with the prognosis of high risk myelodysplastic syndrome (MDS) and MDS/secondary AML
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | High risk myelodysplastic syndrome and MDS/secondary AML |
Date of first enrollment | 2006/04/05 |
Target sample size | 250 |
Countries of recruitment | Japan |
Study type | Observational |
Intervention(s) |
Outcome(s)
Primary Outcome | Efficacy of allo-stem cell transplantation in the survival of high risk MDS and MDS/secondary AML |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 15years-old |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | none |
Related Information
Primary Sponsor | Japan Adult Leukemia Study Group |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Ministry of Health, Labor and Welfare |
Secondary ID(s) |
Contact
public contact | |
Name | Mitsuhiro Matsuda, MD, PhD |
Address | 377-2 Ohno-Higashi, Osaka-Sayama, Osaka Japan |
Telephone | 072-366-0221 |
mmatsuda@med.kindai.ac.jp | |
Affiliation | JALSG MDS206 study office Department of Hematology, Kinki University School of Medicine |
scientific contact | |
Name | Mitsuhiro Matsuda, MD, PhD |
Address | 377-2 Ohno-Higashi, Osaka-Sayama, Osaka Japan |
Telephone | 072-366-0221 |
Affiliation | Kinki University School of Medicine Department of Hematology |